Vivatides Therapeutics
PrivateLast Round
Series A
Apr 10, 2026
Total Funding Raised
$54M
Company Overview
Vivatides Therapeutics is a biotechnology company that is developing a platform for extrahepatic RNA-targeting therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivatides Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Vivatides Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 10, 2026 |
Key People
Founding team and executive leadership
Vivatides Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Highlight Capital | Series A |
| TF Capital | Series A |
| Qiming Venture Partners | Series A |
| Apricot Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Raised $54M in Series A funding.
Vivatides Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivatides Therapeutics's valuation, stock price, and market status.
